Cargando…
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators
Autores principales: | Tanager, Kevin S., Yu, Jovian, Chiu, Brian C-H, Carll, Timothy C., Tatarian, Alexandra H., Riedell, Peter, Smith, Sonali, Kline, Justin, Venkataraman, Girish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968890/ https://www.ncbi.nlm.nih.gov/pubmed/34911281 http://dx.doi.org/10.3324/haematol.2021.279648 |
Ejemplares similares
-
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2022) -
TIGIT is a key inhibitory checkpoint receptor in lymphoma
por: Godfrey, James, et al.
Publicado: (2023) -
Highly clonal regulatory T-cell population in follicular lymphoma – inverse correlation with the diversity of CD8(+) T cells
por: Liu, Xiao, et al.
Publicado: (2015) -
5-Hydroxymethylcytosine: a new kid on the epigenetic block?
por: Matarese, Filomena, et al.
Publicado: (2011) -
Epigenetic
Optical Mapping of 5-Hydroxymethylcytosine
in Nanochannel Arrays
por: Gabrieli, Tslil, et al.
Publicado: (2018)